头颈部癌人乳头瘤病毒检测指南更新
美国病理学家协会召集专家组,按美国国家医学院标准系统综述2018年指南发布后的新证据,采用GRADE方法更新头颈部癌HPV检测推荐。更新涵盖非口咽部位HPV、全球感染率、p16免疫组化及细胞学标本检测性能等,共给出7条强推荐、4条条件推荐和5条良好实践声明。
要点
- 更新基于2018年后新证据,涵盖非口咽部位HPV及细胞学标本检测性能。
- 共给出7条强推荐、4条条件推荐和5条良好实践声明。
- 新增基于鼻窦鳞状细胞癌研究的推荐更新。
核心结论
- 更新指南为不同头颈部标本的HPV检测性质提供方向,包括基于鼻窦鳞状细胞癌新研究的关键更新。
- 目标是改进并尽可能统一不同病理实践环境和不同国家的HPV检测。
研究设计与样本
- 美国病理学家协会召集专家组,按美国国家医学院可信临床实践指南标准更新指南。
- 专家组定义关键问题并系统综述文献,采用GRADE方法基于证据、证据确定性及关键判断更新推荐。
主要发现
- 更新涉及非口咽解剖部位HPV数据、HPV全球感染率、p16免疫组化、细胞学标本HPV检测性能及p16免疫组化作为替代标志物的性能。
- 指南更新共提供7条强推荐、4条条件推荐和5条良好实践声明。
关键数值与推荐
- 7条强推荐、4条条件推荐、5条良好实践声明。
临床怎么用
- 为不同头颈部标本(包括鼻窦鳞状细胞癌)的HPV检测提供方向。
- 为特定场景和实践环境提供扩展指导,以改进和标准化HPV检测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT.—: In 2018, an evidence-based guideline was published by the College of American Pathologists to develop recommendations for the testing, application, interpretation, and reporting of high-risk human papillomavirus and surrogate marker tests in head and neck carcinomas. Substantial new evidence has prompted a review, including data on human papillomavirus (HPV) in nonoropharyngeal anatomic sites, HPV global rates, p16 immunohistochemistry, and HPV testing performance in cytology specimens, and performance of p16 immunohistochemistry as a surrogate marker. OBJECTIVE.—: To assess research published since the release of the original 2018 guideline and to update evidence-based recommendations for HPV testing in head and neck carcinomas. DESIGN.—: The College of American Pathologists convened a panel of experts to update the guideline following the standards established by the National Academy of Medicine for developing trustworthy clinical practice guidelines. The expert panel defined the key questions and performed a systematic review of the literature. Using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach, recommendations were updated on the basis of available evidence, certainty of that evidence, and key judgments. RESULTS.—: Seven strong recommendations, 4 conditional recommendations, and 5 good practice statements are offered in the guideline update. CONCLUSIONS.—: The updated guideline statements provide direction on the nature of HPV testing in various head and neck specimens (including key updates based on new research on sinonasal squamous cell carcinoma) and expanded guidance on specific scenarios and practice settings. The goal is to improve and standardize, where possible, HPV testing across diverse pathology practice settings and different countries.
引用
- Lewis JS, Beadle B, Bishop JA, et al. Human Papillomavirus Testing in Head and Neck Carcinomas: Guideline Update. Arch Pathol Lab Med. 2025. PMID: 40126379. doi:10.5858/arpa.2024-0388-CP
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。